Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. PNR
2. ONON
3. IAUX
4. KKR
5. DAVA
6. MONC:IM
7. MONRY
8. NYXH
9. THO
10. JG

Go back to Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia
(NASDAQ: AMLX) Delayed: 32.39 --0 (-0%)
Previous Close $32.39    52 Week High $ 
Open $32.39    52 Week Low $ 
Day High $32.39    P/E N/A 
Day Low $32.39    EPS $ 
Volume 6,139